US 2016/0256419 A1Published application

Application of fluoxetine to treatment of depigmentation diseases

AssigneeShandong Runze Pharmaceuticals Co., Ltd.

InventorsJing SHANG, Sha LIAO, Yu JIN, Xiaoli TIAN, Guorui ZHAO, Jia ZHOU, Qian WANG, Silin PANG

Life of this patent

Estimating the term…

Abstract

The present disclosure provides methods and pharmaceutical compositions for treating depigmentation diseases such as vitiligo or leukoctricia. The pharmaceutical composition contains a therapeutically effective amount of fluoxetine.

Claims12

Dependent claims

A method for treating a depigmentation disease in a mammal, comprising administering an effective amount of fluoxetine to a mammal in need thereof.

Dependencies are inferred from the claim text.

Facts

Application: 15/156,943Filed 17 May 2016
Priority: CN 201110403173.47 Dec 2011
Published: 8 Sep 2016
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

A61K 31/138
Having aromatic rings , e.g. ketamine, nortriptyline: aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/06
Medicinal preparations characterised by special physical form: ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Family

Application14/364,037Continuation in part · filed 2 Sep 2014
Application15/156,943Continuation in part
US 2015/0065580 A1Published application
US 9,833,424 B2Related patent
US 2016/0256419 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results